Consolidated Balance Sheets - USD ($) $ in Millions	May 31, 2022	Feb. 28, 2022
Current
Cash and cash equivalents (note 2)	$ 391	$ 378
Short-term Investments	272	334
Accounts receivable, net of allowance of $4 and $4, respectively (note 3)	102	138
Other receivables (note 3)	21	25
Income taxes receivable	9	9
Other current assets (note 3)	169	159
Assets, Current, Total	964	1,043
Restricted cash and cash equivalents (note 2)	28	28
Long-term investments (note 2)	30	30
Other long-term assets (note 3)	8	9
Operating lease right-of-use assets, net	46	50
Property, plant and equipment, net (note 3)	38	41
Goodwill (note 3)	841	844
Intangible assets, net (note 3)	505	522
Assets	2,460	2,567
Current
Accounts payable	14	22
Accrued liabilities (note 3 and note 9)	304	157
Income taxes payable (note 4)	13	11
Deferred revenue, current (note 10)	190	207
Total current liabilities	521	397
Deferred revenue, non-current (note 10)	32	37
Operating lease liabilities	60	66
Other long-term liabilities	3	4
Long-term debentures (note 5)	459	507
Total liabilities	1,075	1,011
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable	0	0
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 577,168,941 voting common shares (February 28, 2022 - 576,227,898)	2,880	2,869
Deficit	(1,475)	(1,294)
Accumulated other comprehensive loss (note 8)	(20)	(19)
Total shareholders' equity	1,385	1,556
Total liabilities and shareholders' equity	$ 2,460	$ 2,567
Common outstanding (in shares)	577,168,941	576,227,898